About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Orchid Pharma Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
524372
ISIN Demat
INE191A01027
Book Value
264.97
NSE Code
ORCHPHARMA
Dividend Yield %
0.00
Market Cap
42147.58
P/E
58.39
EPS
14.23
Face Value
10
BSE
NSE
16-Dec-2025 14:54
BSE
NSE
NSE F & O
16-Dec-2025 14:49
BSE
NSE
NSE F & O
Last Price
830.00
Net Change
7.25
% Change
0.88%
Prev.Close
822.75
Open
822.80
High
831.00
Low
815.50
Volume
1204
Last Price
830.40
Net Change
8.65
% Change
1.05%
Prev.Close
821.75
Open
825.15
High
832.95
Low
815.00
Volume
18342
Value
999320
Best Buy
829.60
Best Sell
831.00
Best Quantity
2
Sell Quantity
118
Today's Range
831.00
52-Week High
1998.00
52-Week Low
603.80
Value
15231196.8
Best Buy
830.50
Best Sell
831.40
Best Quantity
1
Sell Quantity
7
Today's Range
832.95
52-Week High
1997.40
52-Week Low
603.80
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
2
Price
829.60
Quantity
118
Price
831.00
Best Bid
Best Offer
Quantity
1
Price
830.50
Quantity
7
Price
831.40
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Bonus
1 : 2
15-Sep-05
Book Closure
03-Aug-23
09-Aug-23
Dividend
30 %
15-Sep-12
Company News
04-11-2025
Clarification sought fro...
18-07-2025
Orchid Pharma executes De...
20-02-2025
USFDA concludes inspectio...
12-11-2024
Orchid Pharma informs abo...
07-08-2024
Orchid Pharma submits ana...
01-07-2024
Orchid Pharma gains on pa...
28-06-2024
Orchid Pharma partners wi...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.
